Related Experiment Video
Updated: May 22, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Non-tuberculous mycobacteria infection: 75 cases
Aylin Babalık1, Tülin Kuyucu, Emine N Ordu
1Clinic of Chest Diseases, Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey. aylinbabalik@gmail.com
Identifying non-tuberculosis mycobacteria (NTM) in sputum is crucial for effective treatment. This study highlights common NTM species and emphasizes culture methods for accurate diagnosis and management.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Non-tuberculosis mycobacteria (NTM) infections occur in both AIDS and non-immunosuppressed patients.
- Evaluating NTM in sputum is vital for clinical management and understanding disease impact.
Purpose of the Study:
- To assess the clinical significance of non-tuberculosis mycobacteria identified in patient sputum.
- To analyze the characteristics, treatment outcomes, and drug resistance patterns of NTM infections.
Main Methods:
- Analyzed sputum samples from 75 patients using rapid tests, NAP test, and Hsp65PCRREA for NTM identification.
- Evaluated treatment management, radiology, bacteriology, co-morbidities, and outcomes from medical records and patient follow-ups.
- Included identification of Mycobacterium abscessus, Mycobacterium avium complex (MAC), and Mycobacterium kansasii.
Main Results:
- Mycobacterium abscessus (28%), MAC (25%), and Mycobacterium kansasii (16%) were the most common NTM identified.
- Treatment was administered to 43 cases, with a cure rate of 58%. Drug resistance was observed in 86% of cases.
- Radiological findings included consolidation (65%) and cavities (37%). Past tuberculosis treatment history was present in 40% of cases.
Conclusions:
- Accurate identification of non-tuberculosis mycobacteria through culture methods is essential for appropriate treatment and epidemiological assessment.
- Understanding NTM species and resistance patterns aids in tailoring patient management strategies.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Atypical Pneumonia